Small-Cap Pharmaceutical Stock Doubles on Positive Data

Never ignore a stock just because it appears to be down-and-out. You may just miss a triple-digit profit opportunity. Look at Axsome Therapeutics (AXSM), for example. Axsome Therapeutics is a clinical-stage biopharmaceutical company, develops therapies for the management of central nervous system (CNS) disorders. The Company’s product candidates include AXS-05 that is in Phase III … Continue reading “Small-Cap Pharmaceutical Stock Doubles on Positive Data”